Diasorin Ltd
COMPANY INFORMATION
DiaSorin is an Italian multinational Group and a global leader in the market for in vitro diagnostics. DiaSorin is listed on the MTA (automated stock market) in the FTSE Italia Mid Cap Index, organized and managed by Borsa Italiana S.p.A
For over 40 years the Group has been developing, producing and commercializing diagnostic tests for a wide range of clinical areas. DiaSorin tests are designed for hospital and private testing laboratories, in the markets of immunodiagnostics and molecular diagnostics.
LATEST STORIES
PRODUCTS AND SERVICES
Latest Issues
Epredia was established in July 2019 through the acquisition by PHC Group of the Anatomical Pathology division of Thermo Fisher Scientific. Our name has changed, however as a standalone business our mission remains the same: to improve lives by enhancing cancer diagnostics.
We are powered by the quality brands you know and trust, such as...
46th European Congress of Cytology
Hilton Antwerp Old Town, Antwerp
4-7 October, 2026
UK NEQAS webinar: Introduction to Cellular Components, Tissue Morphology and Tissue Recognition
Online
6-7 October, 2026
Introduction to Cellular Components, Tissue Morphology and Tissue Recognition Master Class
The Haylofts, St Thomas Street, Haymarket, Newcastle, NE1 4LE, UK
8 October, 2026
Microbe 2026
Crowne Plaza Hotel, Sheffield
9-11 October, 2026
UK NEQAS webinar: IHC Technical Issues and Quality Assurance
Online
13-15 October, 2026